SHL Group (SHL), a designer, developer and manufacturer of drug delivery medical devices, including pen-injectors, auto-injectors and inhaler systems, has formally begun the expansion of its new manufacturing facilities in Taiwan, The BiotechEast reported. This 2000 square meter expansion project includes new machinery for tooling, CNC machining and automation.
The expansion is estimated to not only create new job opportunities, but also provide technology and expertise transferable to local staff in Taiwan.
On October 7, 2008, SHL signed a Letter of Intent (LOI) with the Ministry of Economic Affairs committing to in principal a further $100 million of investment in Taiwan over the next 5 years.
“We are excited to see our company continue to expand and grow. Our goal is to bring in the latest technologies and capabilities to SHL so that we can provide our customers with even more services. Now, SHL has over 1,500 staff globally with 1000 staff in Taiwan. And, I am pleased to announce that we will double in size over the next three years,” said Roger Samuelsson, SHL Group founder and CEO,
The ribbon cutting ceremony featured guests from Taiwan’s Ministry of Economic Affairs, Taoyuan Government, AMCHAM, ECCT and the Swedish Trade Council. After the ceremony, all the guests were taken on a private tour of the new facilities where millions of auto-injectors and pen-injectors are manufactured and distributed throughout the world.